2 results
Approved WMOPending
To evaluate the efficacy and safety of extended release (ER) Niacin/Laropiprant when added to ongoing lipid-modifying therapy in patients with primary hypercholesterolemia or mixed dyslipidemia.
Approved WMOPending
to determine the accuracy/reliability of ultrasound in determining the correct placement of gastric feeding tube expressed as the sensitivity and specificity for this diagnostic test.